Skip to content
OpenCapital
Get started

Chemed CHE Investment Income

Investment Income at other companies

CHE
ChemedCHE
$890K-57.1%
Main Street Capital logo
Main Street CapitalMAIN
$84.58M-1.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$25.48M+3.3%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
$171.31M+76.0%
ESN
Essent GroupESNT
$59.26M+1.8%
Main Street Capital logo
Main Street CapitalMAIN
$87.84M-2.2%

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's investment income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's investment income?
Chemed (CHE) reported investment income of $890K in Q1 2026.
How has Chemed's investment income changed year-over-year?
Chemed's investment income decreased by 57.1% year-over-year, from $2.08M to $890K.
What is the long-term trend for Chemed's investment income?
Over 4 years (2021 to 2025), Chemed's investment income has grown at a 119.6% compound annual growth rate (CAGR), from $376K to $8.75M.
What does investment income mean?
The net income generated from cash balances, marketable securities, and other financial investments after accounting for related expenses. This metric measures the efficiency of the company's treasury management and capital deployment.